ReviewPharmaceutics2023

The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials.

Luxi Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.